send to a friend by email

Jerusalem Pharmaceuticals Company achieves a net income of JD0.88 million in H1 2013

2013-08-15

According to company data for the first six months of the year, net profit after taxes reached 879,087 USD, compared with a net loss of (853,058) USD from the first six months of 2012. Total assets of the company reached 52,614,881 USD as of June 30^th, 2013, compared to total assets of 48,875,519 USD as of December 31^st, 2012, a net increase of 7.7%. Total liabilities of the company reached 17,302,521 USD as of June 30^th, 2013, compared to total liabilities of 15,164,804 USD as of December 31^st, 2012, a net increase of 14.1%. Net ownership equity of the company reached 35,312,360 USD (including 837,484 USD in Non-controlling interest) as of June 30^th, 2013, compared with a net ownership equity of 33,710,715 USD (including 951,501 USD in Non-controlling interest) as of December 31^st, 2012, a net increase of 4.8% in the last six months. Furthermore, paid-in capital increased from 8,530,000 USD on December 31^st, 2012 to 17,060,000 USD by June 30^th, 2013, an increase of 100.0%.